Loading clinical trials...
Loading clinical trials...
Phase II Study of Oxaliplatin, Capecitabine and Bevacizumab in the Treatment of Metastatic Colorectal Cancer
Conditions
Interventions
bevacizumab
oxaliplatin
+2 more
Start Date
September 1, 2003
Primary Completion Date
January 1, 2008
Completion Date
August 1, 2014
Last Updated
September 3, 2014
NCT06696768
NCT04704661
NCT05489211
NCT06625775
NCT04657068
NCT06445062
Lead Sponsor
Herbert Hurwitz, MD
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions